Cancer Therapeutics CRC Pty Ltd - Product Pipeline Review - 2014

Date: September 30, 2014
Pages: 33
Price:
US$ 1,500.00 US$ 1,350.00
Offer valid until December 31, 2014!
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: CD01D4D5AEEEN
Leaflet:

Download PDF Leaflet

Summary

Global Markets Direct’s, ‘Cancer Therapeutics CRC Pty Ltd - Product Pipeline Review - 2014’, provides an overview of the Cancer Therapeutics CRC Pty Ltd’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Cancer Therapeutics CRC Pty Ltd’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • The report provides brief overview of Cancer Therapeutics CRC Pty Ltd including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Cancer Therapeutics CRC Pty Ltd’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Cancer Therapeutics CRC Pty Ltd’s pipeline products
Reasons to buy
  • Evaluate Cancer Therapeutics CRC Pty Ltd’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Cancer Therapeutics CRC Pty Ltd in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Cancer Therapeutics CRC Pty Ltd’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Cancer Therapeutics CRC Pty Ltd and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Cancer Therapeutics CRC Pty Ltd
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Cancer Therapeutics CRC Pty Ltd and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues
Cancer Therapeutics CRC Pty Ltd Snapshot
Cancer Therapeutics CRC Pty Ltd Overview
Key Information
Key Facts
Cancer Therapeutics CRC Pty Ltd - Research and Development Overview
Key Therapeutic Areas
Cancer Therapeutics CRC Pty Ltd - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Cancer Therapeutics CRC Pty Ltd - Pipeline Products Glance
Cancer Therapeutics CRC Pty Ltd - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Cancer Therapeutics CRC Pty Ltd - Drug Profiles
CTX-0294945
Product Description
Mechanism of Action
R&D Progress
Small Molecule Inhibiting Mitosis for Solid Tumors
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit PRMT1 for Cancer
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit USP7 for Cancer
Product Description
Mechanism of Action
R&D Progress
Small Molecules For Cancer
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit FAK-FLT3-VEGFR3 for Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit MELK for Cancer
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit MOZ for Acute Myelocytic Leukemia
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit Ubiquitin E3 Ligase E6AP for Cancer
Product Description
Mechanism of Action
R&D Progress
Cancer Therapeutics CRC Pty Ltd - Pipeline Analysis
Cancer Therapeutics CRC Pty Ltd - Pipeline Products by Target
Cancer Therapeutics CRC Pty Ltd - Pipeline Products by Route of Administration
Cancer Therapeutics CRC Pty Ltd - Pipeline Products by Molecule Type
Cancer Therapeutics CRC Pty Ltd - Pipeline Products by Mechanism of Action
Cancer Therapeutics CRC Pty Ltd - Dormant Projects
Cancer Therapeutics CRC Pty Ltd - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES


Cancer Therapeutics CRC Pty Ltd, Key Information
Cancer Therapeutics CRC Pty Ltd, Key Facts
Cancer Therapeutics CRC Pty Ltd - Pipeline by Indication, 2014
Cancer Therapeutics CRC Pty Ltd - Pipeline by Stage of Development, 2014
Cancer Therapeutics CRC Pty Ltd - Monotherapy Products in Pipeline, 2014
Cancer Therapeutics CRC Pty Ltd - Partnered Products in Pipeline, 2014
Cancer Therapeutics CRC Pty Ltd - Partnered Products/ Combination Treatment Modalities, 2014
Cancer Therapeutics CRC Pty Ltd - Out-Licensed Products in Pipeline, 2014
Cancer Therapeutics CRC Pty Ltd - Out-Licensed Products/ Combination Treatment Modalities, 2014
Cancer Therapeutics CRC Pty Ltd - Preclinical, 2014
Cancer Therapeutics CRC Pty Ltd - Discovery, 2014
Cancer Therapeutics CRC Pty Ltd - Pipeline by Target, 2014
Cancer Therapeutics CRC Pty Ltd - Pipeline by Route of Administration, 2014
Cancer Therapeutics CRC Pty Ltd - Pipeline by Molecule Type, 2014
Cancer Therapeutics CRC Pty Ltd - Pipeline Products by Mechanism of Action, 2014
Cancer Therapeutics CRC Pty Ltd - Dormant Developmental Projects,2014

LIST OF FIGURES


Cancer Therapeutics CRC Pty Ltd - Pipeline by Top 10 Indication, 2014
Cancer Therapeutics CRC Pty Ltd - Pipeline by Stage of Development, 2014
Cancer Therapeutics CRC Pty Ltd - Monotherapy Products in Pipeline, 2014
Cancer Therapeutics CRC Pty Ltd - Partnered Products in Pipeline, 2014
Cancer Therapeutics CRC Pty Ltd - Out-Licensed Products in Pipeline, 2014
Cancer Therapeutics CRC Pty Ltd - Pipeline by Top 10 Target, 2014
Cancer Therapeutics CRC Pty Ltd - Pipeline by Top 10 Molecule Type, 2014
Cancer Therapeutics CRC Pty Ltd - Pipeline Products by Top 10 Mechanism of Action, 2014

Ask Your Question

Cancer Therapeutics CRC Pty Ltd - Product Pipeline Review - 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: